TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein tied to cellular structure and movement.
Preclinical research has looked at TB-500 in the context of actin regulation (actin being a core part of the cell's cytoskeleton), cell migration and tissue-repair models. It's often studied alongside BPC-157 in recovery research, which is why the two frequently appear together as a blend.
As with the other peptides in this category, the evidence is preclinical and TB-500 is not an approved medicine. It is treated strictly as research material.
Each vial is supplied lyophilised and HPLC-tested to at least 99% purity.
This article is for educational and research-reference purposes only. It is not medical advice. All products are supplied strictly for in-vitro laboratory research use, not for human or veterinary consumption.